Table Of Content

AUTHOR INDEX JANUARY 1, 1997 THROUGH JUNE 15, 1997 Aarge J, 19 Ash AS, 22 Bell MR, 1005 Brevetti G, 777 Chaitman BR, 253, 451 Abe M, 615 Assali A, 672 Bellotti G, 1323 Briggs B, 1114 Chakko S, 106 Abe Y, 362 Assanelli E, 1120 Bell TJ, 1281 Brignole M, 1421 Chambless L, 722 Abel J, 81 Assheuer J, 959 Benamer H, 1527 Bristow MR, 794 Chan DP, 1552 Abizaid A, 703 Asvar CA, 384 Bender AM, 696 Brodie BR, 3 Chang M-S, 11, 683, 905, Achenbach S, 856 Atkins DL, 1147 Benhamda K, 4 Brodkey FD, 840 974 ACIP Investigators, 889 Atorvastatin Study Group |, Bennett SI, 1302 Brogan GX Jr., 1110 Charbonnier B, 727 Acufia JMG, 373 1475 Bennett WM, 415 Brouwer J, 978 Chareonthaitawee P, 1295 Adachi T, 1329 Aubrey B, 1092 Bensky AS, 982 Brown DL, 878 Charles JB, 1153 Adamopoulos S, 14 Aung M, 1092 Berdan LG, 286, 590, 748 Brubaker PH, 360 Charlesworth A, 1364 Adams MG, 639 Aursnes |, 115 Berger PB, 1005 Brugada J, 681 Chau EMC, 31 Adele C, 513 AVID Investigators, 1185 Berger R, 970 Brundage BH, 128 Chaudry F, 1518 Adele SB, 545 Awaad Ml, 706 Bergfeldt L, 1241 Buchbinder M, 305 Chauvel C, 713 Adelman AG, 867 Ayzenberg O, 727 Berglund H, 1564 ; Buchbinder N, 1521 Chen CC, 781 Aepfelbacher FC, 826 Berkowitsch A, 205 Bucher TA, 6 Chen S-A, 11, 683, 905, Aeschilman S, 645 Baba Y, 1097 Berman A, 1159 Buck DL, 209 974 Afridi |, 1309 Babu R, 1334 Berman D, 1521 Buda AJ, 742 Chen Y-J, 683, 905, 974 Agostoni P, 1120 Bach DS, 365 Berman DS, 1319 Budaj A, 768 Cheng J-J, 905, 974 Aguirre F, 1441 Bachmann K, 856 Bernies M, 1100 Budoff M, 128 Cheriex E, 334 Aharonian VJ, 553 Bacon J, 1307 Berry JJ, 3 Bugiardini R, 957 Cherrier F, 1389 Ahn C, 379, 525, 991, Baga JJ, 963 Bertaglia E, 500 Buller E, 81 Cheung K-L, 31 1432, 1543 Baget F, 1230 Besse P, 545 Burch M, 834 Chiang C-E, 11, 683, 905, Akasaka T, 20, 223 Bagger JP, 9 Bettica P, 84 Burden L, 1397 974 Akimoto K, 1137 Bahawar H, 205 Beurrier D, 154 Burelle D, 829 Chiba M, 966 Akosah KO, 48 Baig K, 834 Bevilacqua M, 84, 1498 Burke JH, 178 Chikamori T, 29 Alazraki NP, 406 Baig MK, 1135 Bhambhani G, 323 Burns TL, 645 Chin MH, 13 Albano MP, 292 Baiker WM, 1401 Bigi R, 733 Bussiéres LM, 630 Ching EA, 686 Albertsson P, 299 Baim DS, 1159, 275 Billie M, 807 Byrd BF Ill, 232 Chiou C-W, 683, 974 Bakker-Arkema R, 1475 Alboni P, 1421 Bink-Boelkens MThE, 92 Chlouverakis Gi, 160 Bakker PFA, 334 Cabot CF, 286 Alfonso F, 191, 1394 Birnbaum Y, 1155, 1568 Cho S, 68, 1232 Baliga RR, 1397 Cadence Investigators, 820 Ali OS, 4 Bischoff N, 1389 Cho S-Y, 901 Ballard EA, 1258 Cador R, 4, 1389 Al-Khaled N, 94 Bishop SL, 1153 Chow W-H, 31 Baller D, 988 Caforio ALP, 1135 ALKK Study Group, 264 Black D, 1475 Christensen JH, 19 Balster DA, 1552 Caguoia E, 292 Allen HD, 344, 1552 Blanc J-J, 1276 Christian TF, 1295 Banasiak W, 14 Caiero T, 1135 Allen RH, 799 Blankenship JC, 984 Christopoulou-Cokkinou V, Bandini P, 733 Calabrese G, 245 Almeida OD, 559 Blanksma PK, 108 494 Banker J, 816 Caldwell MA, 639 Alpert JS, 1025 Bloch Y, 611 Chrysostomakis SI, 160 Banner N, 7 Califf RM, 286, 539, 590, Al-Shaibi KF, 472, 1334 Blumberg FC, 1273 Chu S-H, 1546 Bafiuelos C, 1394 748, 867, 1232 Alt E, 621 Bobadilla JF, 670 Chua TP, 14 Banuelos C, 191 Calkins H, 970 Alwi M, 1430 Bock A, 959 Churchill D, 1436 Barbir M, 7 Calvin JE, 259 Amanullah AM, 1319 Boissel J-P, 587 Cianflone D, 1 Bar FW, 727, 1012 Camino A, 436 Ambrose JA, 559 Barenfanger P, 1360 Boland JP, 727 Camm AJ, 785 Ciavolella M, 1261 Amerena J, 1255 Bolognesi R, 242 Cigarroa JE, 1493 Barilla F, 1261 Campa PP, 1261 Amin RD, 38 Barletta G, 78, 777 Bonaduce D, 564 Campbell RWF, 213 Claes G, 1447 Ammer R, 621 Barnard RJ, 1112 Bongarzoni A, 1433 Campolo L, 188 Clark M, 58 Amuchastegui M, 1135 Barnhart HX, 1453 Bonso A, 1421 Camunas J, 1054 Clegg L, 722 Anderson HV, 286, 1441 Barold SS, 1226 Borenstein D, 68 Cannom DS, 1185 Clements SD, 781 Anderson JL, 43 Baron Jl, 600 Borer JS, 1070, 1482 Cannon C, 391 Coats AUS, 14, 1426 Anderson KM, 286 Barr CS, 328 Borges-Neto S, 851 Cannon CP, 253, 1441 Coggins K, 436 Andrews R, 1364 Barron HV, 1180, 1417 Borras X, 15 Capehart J, 532 Cohen A, 713 Angiot M, 1389 Barron MK, 742 Borreson TE, 377 Caputo RP, 275, 1159 Cohen D, 1307 Angoli L, 188 Barry JM, 415 Borst C, 402 Cardoso A, 226 Cohen DJ, 275, 1159 Anguissola GB, 1100 Bart BA, 1118 Borzak S, 94 Carere RG, 81 Cohen EA, 867 Anker SD, 14, 1426 Barth H, 727 Boscarini M, 188 Carney RM, 511 Cohen MC, 1512 Antiarrythmias Versus |m- Barth-Jones D, 1370 Boschi S, 957 Carotti A, 1498 Cokkinos DV, 494 plantable Defibrillators Bartunek J, 478 Botker HE, 9, 961 Carravallah DJ, 691 Coleman RE, 851 (AVID) Trial Executive Com- Barzilay J, 674 Bourdarias J-P, 635 Carreras F, 15 Coletta C, 733 mittee, 661 Bass T, 286 Bourke JP, 213 Carrozza JP, 1159 Colonna G, 1, 1174 Apicella C, 564 Basson CT, 994 Bove EL, 1143 Carrozza JP Jr., 275 Come PC, 292 Apperson-Hansen C, 13 Bax JJ, 7, 883 Bovill EG, 391 Casazza F, 1433 Connolly HM, 519 APSI Investigators, 587 Baxley WA, 472, 1334 Bowker T, 7 Cassagneau B, 1100 Conti CR, 889 Arakawa K, 197 Beanlands RSB, 1092, 1518 Boyko V, 674, 717 Cavallaro V, 564 Conti JB, 1412 Arakawa N, 966 Beaufort-Krol GCM, 92 Boyne TS, 270 CAVEAT-I Investigators, 748, Conti M, 242 Arbustini E, 188 Becker HJ, 1360 Bradley WA, 1465 867 Conti VR, 23 Armstrong PW, 1232 Beckham V, 216 Bramwell 0, 703 CCAT Investigators, 867 Contreras G, 106 Armstrong WF, 365 Beekman RH Ill, 1141, 1143 Branzi A, 1314 Cecchetti A, 1264 Cook EF, 292 Armell H, 521 Beevers DG, 1436 Braunwald E, 253, 391, Ceci V, 733 Cooke CD, 406 Arnett DK, 1289 Beevers M, 1436 1441 Cedillo-Salazar FR, 1408 Cooke D, 2 Arnold KJ, 1549 Behar S, 674, 717 Breekland A, 108 Centonze F, 1433 Cooper L, 722 Aronow WS, 379, 525, 991, Bekedam MA, 773 Breithardt G, 468 Ceremuzynski L, 768 Corcos T, 1230 1432, 1543 Bell BM, 840 Brembilla-Perrot B, 154 Cerrato JC, 373 Cornel JH, 883 Ascah KJ, 1518 Beller GA, 270, 709, 986 Brener SJ, 13, 1460 Cetta F, 1281 Cord L, 1421 ©1997 by Excerpta Medica, Inc. All rights reserved. Coronary Artery Regression de Marchena E, 706 El-Said GM, 7 Fortini A, 1174 Goldberg RJ, 1095 Study (CARS) Group, 893 DeNadai L, 33 Elsner D, 1273 Fouad-Tarazi FM, 100 Goldberg S, 1104 Correa SD, 75 Denfield S, 1561 Elvelin L, 996 Fowler MB, 58 Goldberg SJ, 696 Corretti MC, 350 den Heyer P, 1012 El-Zeky F, 847 Fragakis N, 366 Goldberger AL, 371 Corti M-C, 120 Dent JM, 16 Emanuelsson H, 299, 1447 Francalanci P, 245 Goldberger JJ, 178, 822 Costanzo MR, 1124 DeQuattro V, 1025 Embon P, 355 Franceschi M, 500 Goldbourt U, 674, 717 Coste P, 545 de Roos A, 773 Enalapril-Felodipine ER Fac- Franklin BA, 1075 Goldman JH, 1135, 1203 Covitz W, 982 Desai PV, 182 torial Study Group, 431 Frankovich D, 963 Goldman L, 13, 292 Cowley AJ, 1364 De Servi S, 188 Endo A, 32 Freed LA, 1482 Goldstein S, 105 Coyne EP, 209 de Simone G, 1070 Endo T, 1292 Freediand KE, 511 Golub RJ, 600 Cozier IG, 1302 De Simone G, 1498 Epstein AE, 1185 Freis RP, 1194 Gomes JA, 1054 Crake T, 21 D'Este D, 500 Ergin A, 1054 Freitas A, 226 Gonzalez-Juanatey JR, 373 Cranney GB, 626 Detrano RC, 1236 Eriksen UH, 961 Friedman DB, 281 Goodman Kd, 128 Craver JM, 1453 Devereux RB, 1070, 1482 ESMIR Research Group of Friedman JD, 1319 Goods CM, 472, 1334 Crea F, 1, 1174 Diamond JA, 505 the Interuniversity Cardiol- Friedman R, 1025 Gorcsan J Ill, 1036 Crean P, 980 Dib J-C, 635, 713 ogy Institute of The Nether- Friman G, 521 Gordon NF, 763, 1065 Crijns HJGM, 53, 108, 978 Diebold B, 713 lands, 334 Frimerman A, 72 Gore JM, 391, 1095 Cucherat M, 587 Diem SJ, 1118 Espinal M, 436 Fuji H, 1329 Gosselink ATM, 53 Cucinelli F, 1174 Diesto JT, 553 ESVEM Investigators, 315, Fujii M, 862 Goto Y, 5, 1534 Cuilliére M, 1389 ‘Ji lorio A, 777 1048 Fujikawa H, 1131 Gottlieb S, 23 Curtis AB, 1185, 1412 DiLauro SC, 1112 Ethevenot G, 1389 Fujimoto Y, 32 Gottlieb SS, 679, 1267 Cutler D, 23 Dinerman JL, 970 Etienne Y, 1276 Fukazawa H, 1131 Gotto AM Jr., 17 Cutler NR, 431 Dinis M, 226 Eto K, 1471 Fukuda K, 615 Gradel C, 1 Czajkowski SM, 1017 Dizon J, 816 Eto T, 1556 Fukuda N, 615, 921 Gradman AH, 431 Czeizel AE, 140 Diuzniewska M, 768 Etsuda H, 197 Fulmer H, 595 Graham LC, 1281 Dobrinska MR, 38 Evans F, 621 Furniss SS, 213 Gray JR, 1017 Dodek AA, 81 Evans JJ, 207 Furuno T, 29 Grayburn PA, 1309 Daikoku S, 1534 Doelling N, 447 Fyfe D, 447 Greenwald G, 58 Dal Bello B, 188 Doi YL, 29 Gregorini L, 1100 Dalessandro DA, 1114 Doig JC, 213 Fagan J, 2 Grewal KS, 553 Dallapiccola B, 245 Domanski MJ, 909 Faggiano P, 219 Galati A, 733 Griffin BP, 914 D’Aloia A, 219 Dominguez M, 829 Fajadet J, 1100 Gallagher JJ, 600 Grill DE, 1005 Daly AL, 1381 Donald RA, 1302 Falcon-Eicher S, 33 Gallino R, 538 Grobbee DE, 103 Daly B, 10, 150 Donnerstein RL, 696 Fan P, 436 Gallo P, 245 Grudzka K, 768 Damiano RJ Jr., 48 Donohue TJ, 451 Fang Q, 213 Gan TE, 339 Grundy SM, 1298 Danchin N, 1389 Doornbos J, 773 Fantini F, 78 Gangadharan C, 1370 Gualeni A, 219 Dangas G, 559 Dos Santos P, 545 Favereau X, 1230 Garcia-Cantu E, 4, 1230 Guazzi M, 1120 Daniels C, 1307 Douglas JS Jr., 1453 Fayyad R, 1475 Garcia EJ, 670 Guazzi MD, 1120 Daniels SR, 380 Douthat L, 94 Feldman AM, 1128 Garcia EV, 406 Guerci AD, 128 Danish Verapamil Infarction Doyle TK, 820, 1408 Feldman T, 253 Gardner TJ, 112 Guéret P, 713 Trial (DAVIT) Study Group, Drew BJ, 145, 639, 1043 Feliciano Z, 679 Garot P, 1527 Guérin Y, 1230 738 Dries DL, 909 Felner JM, 1269 Garratt KN, 1005 Guillo P, 1276 Danzi G, 188 Drory Y, 355 Felner KJ, 1269 Gattis WA, 1118 Gulati VK, 1036 Daoud E, 97, 815 Drott C, 1447 Fenster PE, 1025 Gebara OCE, 1252 Giilker H, 264 Davidson M, 1475 Dubourg 0, 635 Fenwick M, 328 Geggel RL, 1279 Gumbrielle TP, 213 Davidson MH, 38 Duclos F, 545 Ferguson JJ, 286 Geleijnse ML, 7, 883, 1031 Guralnik JM, 120 Davidson PM, 626 Ducot B, 1343 Fernandez-Ortiz A, 191, Geller NL, 889 Gussenhoven EJ, 699 Davidson-Ray L, 590 Duff HJ, 1339 1394 Gelman J, 339, 516 GUSTO-I Investigators, 1232 Davies G, 21 Dujovne C, 38 Ferreira AC, 706 George BS, 590 Gutgesell HP, 344 Davila-Roman V, 511 Dujovne CA, 1387 Ferrucci L, 120 Gersh BJ, 909 Gutstein H, 991, 1543 Davis PJ, 431 Duncan JJ, 1065 Filart RA, 1114 Geschwind HJ, 1343 Guyton RA, 1453 de Albuquerque CP, 1323 Dunn FG, 727 Finch A, 436 Geselschap JH, 699 Dean LS, 472, 1334 Dupouy PJ, 1343 Fiorentini C, 733 Ghaisas NK, 980 Deanfield JE, 834 Dupuis G, 1017 Fioretti PM, 1031, 7, 883 Ghali WA, 22 Hachamovitch R, 1521 Deblock H, 1153 Dyerberg J, 19 Fischman DL, 1104 Ghandour G, 58 Hadi BU, 1488 de Bruijne MC, 103 Fishbein MC, 1564, 1568 Gianfranchi L, 1421 Haerten K, 727 de Bruyne B, 478 Fisher EA, 1281 Gibbons RJ, 19, 812, 1295 Hagendorff A, 28 DeBusk RF, 58 Earle NR, 820 Fisher ML, 679, 1267 Gibson RS, 253, 1441 Hagerup L, 738 Deckers JW, 103 EAST Investigators, 1453 Fisman EZ, 355 Giles TD, 377 Hahin E, 315, 1048 De Graeff PA, 978 Eaton G, 1307 Fitzgerald PJ, 384 Gilligan DM, 1226 Hahn KH, 2 DeGroot P, 12 Egerer KR, 1426 Fitzpatrick PJ, 1106 Gillis AM, 1339 Haigney MCP, 970 Dehmer GJ, 1245 Ehlert FA, 178 Flatley MG, 275 Giordano A, 219 Haim M, 674, 717 De lasio R, 957 Ehsani AA, 1258 Fleischmann KE, 292 Giorgberidze |, 12, 323 Hakimi M, 1283 de Kam PJ, 53 Eicher J-C, 33 Fletcher RD, 1424 Girgis |, 106 Haley WE, 1255 deKemp RA, 1092 Eichhorn EJ, 794 Flevari P, 26 Giroud M, 33 Haliassos A, 494 de la Chaise AT, 154 Eisenberg MJ, 867 Flevari PG, 482 Giudici MC, 209 Hall L, 1075 Delacrétaz E, 185 Eisenberg SJ, 1043 Fligner DJ, 2 Given MB, 377 Hall RE, 22 Del Bene R, 78 El-Banayosy A, 988 Fogel Ri, 207 Glasser SP, 1401 Hallstrom AP, 1185 Delcan JL, 670 Elefteriades JA, 1 Foley B, 980 Gleichmann U, 988 Hamada M, 1530 Deleon SY, 1281 Elhendy A, 7, 883, 1031 Fong A-N, 905 Globits S, 234 Hamaguchi H, 1097 Delise P, 1421 Elkayam U, 1061 Fontana F, 957 Go BM, 954 Hamdan MH, 1417 Dell'italia LJ, 1261 Ellenbogen KA, 48, 1226 Fontana ME, 1307 Goggins M, 980 Hamer JPM, 334 Delonca J, 1375 Ellerbeck EF, 581 Foo TKF, 234 Goicolea J, 191, 1394 Hamm C, 727 DeLuca S, 1460 Ellis SG, 13, 1460 Forman SA, 889 Gold JA, 581 Hammarstrom E, 52% de Luna AB, 15 Elmfeldt D, 996 Forrester JS, 790 Gold MR, 10, 150, 502, 679 Hammerstein U, 27 De Lurgio DB, 1409 El-Refaee M, 7 Forssmann-Falck R, 651 Goldberg AD, 94, 105 Hammes LN, 1005 1724 THE AMERICAN JOURNAL OF CARDIOLOGY® VOL. 79 JUNE 15, 1997 Hammill SC, 19 Holmes DR Jr., 793, 1005 Jonas RA, 228 Kerber RE, 645, 689 Kormos RL, 1128 Hammill WW, 344 Honda Y, 384 Jonason T, 521, 1507 Keren A, 23 Kornowski R, 6, 703, 717 Hansen Cu, 3 Honeycutt S, 447 Jondeau G, 635 Keren G, 72 Korovesis ST, 803 Hansen JF, 738 Hong MK, 538, 703 Jones EL, 1453 Kerins DM, 232 Korup E, 19 Hanssen M, 727 Hong M-K, 901, 1524 Jones ME, 406 Kerut EK, 377 Kosaka H, 526, 1538 Hara K, 801 Hongo Y, 5 Jones RH, 851 Kesler K, 851 Kosinski AS, 1453 Harada K, 173, 442, 693 Hoogwerf B, 1017 Jordan MO, 742 Kessler KM, 106, 706 Koskinen P, 487 Harcombe A, 30, 1239 Hopkins G, 727 Jorgensen MB, 553 Ketierer MW, 1170 Kostuk W, 1518 Hardage ML, 820 Hori M, 475, 526, 1538 Josephson ME, 371 Khalighi K, 10, 150, 502 Kostuk WJ, 630 Harms V, 305 Horvath G, 822 Joshi V, 691 Khan HH, 1180 Kowey PR, 1114 Harper RW, 339, 516 Horwood L, 97 Juilliére Y, 1389 Khattar RS, 8 Kox WJ, 1426 Harrington D, 14 Hougen TJ, 112 Jukema JW, 773 Khoury Z, 23 Krakoff LR, 505 Harris G, 339 Houplon P, 154 Juliard J-M, 1527 Kiat H, 1319, 1521 Krause L, 1255 Hartz V, 315, 1048 Hozumi T, 20, 223 Jung JK, 1194 Kiefe C, 581 Krawezynska EG, 406 Hasdai D, 1005 Hsu K-L, 1546 Jung W, 28 Kijima Y, 475 Kremastinos DT, 26 Hashimura K, 475 Huang J-L, 683, 974 Justis D, 2 Kim C-J, 1564 Kremastinos DTh, 87, 366, Haskell W, 34 Hunninghake DB, 38 Kim J-J, 901, 1524 482, 666, 803 Hatada K, 362 Hwang J-J, 497 Kim K-B, 901 Kresowik TF, 581 Hattel LU, 286 Kadish AH, 178, 822 Kim K-S, 436, 901 Kreutzer J, 228 Haung J-L, 905 lanniciello A, 564 Kalabalikis AK, 570 Kim KY, 371 Krittayaphong R, 954 HHaawykaiknasw a M,H ,1 316249 2 IIcbrhakhhiamn MK,M ,5 087, 883 KKaalliiln-aF ilAh,o 1R4,0 1323 KKiimmb alSl, 1T1R3,1 380 KKrroolm eRrB , EP1,2 , 1322733 Hayasaka K, 838 \deker T, 621 Kaliner A, 1241 Kimura S, 1149 Kronzon |, 379, 991, 1543 Hearne M, 1465 lida H, 25 Kallner G, 1241 King SB Ill, 1453 Krumholz HM, 581 Hebeler RF Jr., 166 Ikari Y, 801 Kalman JM, 1043, 1180, Kinugawa T, 32 Kruse JT, 178 Heisel AG, 1194 Ikeda U, 1131 1417 Kirk MM, 502 Kryzhanovski VA, 986 Hellemans IM, 334 \kram H, 1302 Kamel A, 213 Kirklin J, 436 Kubo N, 862 HHeelllleerr KG,V ,1 168000 IIlnlaidnag woMr,t h 10D9R,7 38 KKaammiihyaat aT , H1,5 3566 2 KKiittaakmauzrea MK,, 467756,, 512565,6 1538 KKuugglieyra mJaD , K8,4 600 6 Heller RS, 58 Inbar S, 822 Kamp 0, 1355 Kitaoka H, 29 Kuhn H, 264 Hendel RC, 1518 Ing FF, 535, 1561 Kampe LM, 2 Kitayama H, 1292 Kumar A, 388 Hennekens CH, 120, 799 Inkeles SB, 1112 Kan JS, 112 Kiuchi K, 1292 Kunieda T, 1502 Hennen J, 581 Ino T, 1137 Kandavel G, 1430 Kiyonaga A, 360 Kuntz RE, 1159 Henriksen E, 521, 1507 Ip J, 1054 Kang J-C, 901 Kjekshus J, 64, 115 Kuo C-T, 424 Henry AC Ill, 166 Ishihara M, 1392 Kang LM, 1430 Kleesiek K, 988 Kupari M, 487 Henry PD, 820, 1408 Ishii M, 442 Kangawa K, 1556 Kleiger RE, 511 Kurisu S, 1392 Hepner AM, 365 Ishikawa K, 1165 Kangro T, 521, 1507 Kleiman NS, 253, 286, 391 Kurita A, 197, 676 HHeerrabse rtMs,o n 72R7, 1114 IIssnheirk urJaM ,F ,8 7183 29 KKaanot oWr, K1R,1 2444 7 KKlleeiinn LRCW,, 1215895 KKuusrnoidcak HB,A ,3 27 42 HHeerrldit zJ AJ,, 219091 7 IIsssohjiikmi a TK,, 118,9 71 471 KKaapplliinnsskkyy EE,, 661714 KKlleeirns y W,C, 712878 KKvwaoskn ic0k-aH , J,3 11 343 Karagounis LA, 43, 315 Kyo S, 1149 HHHeeerrrmnmiaadnnad ezSJ D-,SR ,, 6 011039 71,5 1394 IIlttuooc hh Si ,A ,A6 ,1 1565,13 54,9 219 21 KKKaaarrraactkheamlawe ar R,AM W,4, 0 366 827 3 KKKlllioignnfetireml adlR mAP ,, G11B41G85,2 5 1405 KKyyortiaankii deSs, Z1S5,0 28 7, 666, 803 Herrold EM, 1070 lwanaka H, 862 Karita M, 526 Klos J, 768 Herz |, 672 lwasaka T, 362, 1097 Karlsson T, 299 Knatterud GL, 391, 889, Lagerberg G, 299 Hessions W, 2 lyer SS, 472, 1334 Kashiro S, 1165 1017, 1441 Laham CL, 19 Heston TF, 415 Kataoka H, 193 Knopp RH, 38 Laham RJ, 275 Hettleman B, 1465 Jaarsma W, 334 Kato Y, 475 Knudtson ML, 1339 Lahiri A, 8 Heublein B, 89 Jacobs AK, 748 Katritsis DG, 803 Knuuti J, 25 Lam LC, 590 Hibbs MS, 878 Jacquemin L, 154 Katsube Y, 526 Kobayashi N, 862 Lamas G, 1570 Higgins CB, 234 Jaeger FJ Jr., 100 Katsuki T, 862 Kobayashi Y, 1534 Lamm C, 299 Hijazi ZM, 1279 Jain AC, 807 Katz WE, 1036 Kobrin |, 1025 Landau C, 1309 Hildick-Smith D, 30 Jain SP, 472, 1334 Kaul S, 16 Koch A, 264 Landelius J, 521 Hillen B, 402 Jais C, 545 Kaushik RR, 12 Kochiadakis GE, 160 Langberg JJ, 1409 Hillis LD, 412, 492, 1493 Jang Y-S, 901 Kavesh NG, 10, 150, 502 Kodama K, 1329, 1530 Lange RA, 412, 492, 1493 Hilton JD, 81 Janosko K, 1264 Kawagoe T, 1392 Koerfer R, 988 Laniado S, 72, 611 Hilton TC, 595 Jansen WC, 959 Kawai S, 1137 Koerner MM, 988 Lansky AJ, 6 Himmrich E, 1360 Japan Cholesterol Lowering Kawano H, 606 Koertke H, 988 Lanza GA, 1, 1174 Hiramori K, 966 Atorvastatin (J-CLAS) Kawaratani H, 1097 Kohli V, 424 Lanzone A, 1174 Hirashima 0, 606 Study, 1248 Kawazoe K, 966 Kokkinos PF, 1424 Laragh JH, 1070 Hirata S, 1165 Jardine DL, 1302 Keane JF, 228 Kolettis TM, 323 Larrazet FS, 1343 Hirayama A, 1329 Jarry G, 1375 Kearney M, 878 Kélsch B, 1549 Latiff HA, 1430 Hiwada K, 1530 Jayaweera AR, 16 Keeler GP, 748 Komatsu H, 838 Lauri G, 1120 Hnatkova K, 1203 Jeffords PR, 742 Keeley EC, 412 Kondo K, 18 Lavery CE, 1512 Ho KKL, 275, 371, 1159 Jencks SF, 581 Keeling PJ, 1203 Konishi H, 1097 Lavie CJ, 397, 664 Hochreiter C, 1482 Jenkins E, 68 Keil J, 1289 Kontos MC, 48, 182 Lawrence JH, 970 Hod H, 674, 717 Jensen CD, 34 Kelder JC, 1350 Kontoyannis D, 529 Lazem F, 7 Hodge DO, 812, 1295 Jesse RL, 182 Kelleher D, 980 Kontoyannis DA, 570 Lee CW, 1524 Hoebrechts R, 418 Joglar JA, 412 Kellett MA, 1465 Kontoyannis SA, 570 Lee KL, 1232 Hoes AW, 103 Johansen H, 1092 Kelly PA, 203 Kooner JS, 1397 Lee PJ, 834 Hoffmann R, 951 Johnson GL, 535 Kelly TA, 3 Koplan BA, 270 Lee RJ, 1043 Hofman A, 103 Johnson JV, 1061 Kemp WE Jr., 232 Kopp H, 1549 Lee RT, 292 Hollander JE, 1110 Johnson MR, 1124 Kengen RAM, 108 Koretsune Y, 526 Lee S-H, 11, 683, 905, 974 Holmer SR, 1273 Johnson PA, 292 Kent KM, 6, 703, 793, 951 Korf B, 994 Lee TH, 292 AUTHOR INDEX 1725 Lee T-M, 1546 Lurje L, 1447 McKenna WJ, 834, 1135, Monsegu J, 4 Nielsen TT, 9 Lee Y-T, 1546 Luthern L, 914 1203 Mont L, 681 Nieminen MS, 487 Leeman DE, 1106 Lynch M, 781 McKenney J, 1475 Moorehead CP, 1143 Nierop PR, 7, 883 Lefer DJ, 742 McLaughlin BA, 595 Moos SP, 16 Niinikoski H, 25 Lehmann G, 621 McMahon WS, 535 Morady F, 815, 97 Niinuma H, 966 Lehmann MH, 963 Macaya C, 191, 727, 1394 Mehdirad AA, 1541 Morales DLS, 1 Niklasson A, 996 Lehtinen R, 1414 MacGowan GA, 1128, 1264 Mehra A, 1061 Morbini P, 188 Niklasson U, 521 Leier CV, 1307 MacRae CA, 994 Mehra R, 12 Moreno R, 670 Nikolaou N, 87 Leimberger JD, 590 Magnani B, 1314 Mehta A, 807 Mori |, 475 Nisam S, 468 Leino EV, 150 Maheu B, 1276 Mehta D, 1054 Mori M, 32 Nishikado A, 921 Leizorovicz A, 587 Mahler CM, 1036 Mehta J, 1558 Mori T, 32 Nishikimi T, 1556 Lekakis J, 529 Mahr NC, 1570 Mehta MC, 807 Morice M-C, 727 Nishimoto K, 1137 Lembo NJ, 1453 Main ML, 1309 Meier B, 185 Morii |, 1534 Nishioka T, 1564 Leon A, 1409 Maixner W, 954 Meier M, 1541 Morillo C, 1226 Nixon JV, 48 Leon MB, 6, 13, 538, 703, Malenka DJ, 1465 Meinert R, 1549 Morioka S, 20 Noble EG, 630 951 Mali WPTM, 402 Melino MR, 38 Morpurgo M, 1433 Node K, 526, 1538 Leonard JV, 834 Malik M, 785, 1203 Melita-Manolis H, 494 Morris DC, 1453 Nolan J, 203 Lerakis S, 23 Malmivuo J, 1414 Mellemgaard K, 738 Morrow WR, 691, 1283 Nonogi H, 1534 Lerner G, 128 Malov N, 611 Melton IC, 1302 Mortensen LS, 738 Norbiato G, 84 Lesbre J-P, 1375 Man KC, 97, 815 Menapace FJ, 984 Mosca RS, 1143 Norman DJ, 415 Lesch M, 105 Manabe K, 615 Mendonéa |, 226 Moshage W, 856 Northern New England Car- Lesh MD, 1043, 1180, Manca C, 242 Menozzi C, 1421 Moskowitz MA, 22 diovascular Disease Study 1417 Mangiaracina F, 1261 Menzel T, 1549 Mostaza JM, 1298 Group, 1465 Leung DY, 626, 914 Mangieri E, 1261 Mera F, 1409 Mosterd A, 103 Nossen J, 856 Levi E, 1 Mann DE, 315 Mercier L-A, 829 Motoyama T, 606 Nowak B, 1360 Levine AB, 105 Mann DL, 1128 Merliss A, 994 Motro M, 355 Nozaki N, 28 Levine BD, 281, 763 Mannebach H, 988 Messerli FH, 27, 788, 826 Moulopoulos S, 529 Nunez E, 826 Levine GN, 748 Manolis AS, 494 Metcalf MD, 679 Moulopoulos SD, 570 Nuutila P, 25 Levine TB, 105 Mansourati J, 1276 Metz JA, 384 Moussari A, 545 Nystrom-Rosander C, 521 Lévy S, 815 Mansukhani PW, 553 Meyer H, 988 Muller JE, 253, 1106, 1252, LLeewwiiss JS,M ,6 4857 3, 1106 MMaannztoolvia nA , R1, 500, 1421 MMiecyhearl eJw,i c7z2 7,L , 1832660 , 1549 Mu1l5li1n2s CE, 1561, 535 OO'cBcrhiie nG ,J C7 3J3r ., 1306 Leya F, 748 Mao S, 1236 Michel U, 205 Muncy DB, 3 Ochiai M, 18, 1471 LLiiabue rCm-aSn, H1A5,4 61 453 MMaarocuenlilsa TCNP,, 469943 MMiicchhieel s DRD,, 712470 1 MMuurnasliif SA,N ,1 12182, 1264 OOc'kCoennneo rI S,C M1,0 951 118 Lichodziejewska B, 768 Marcelletti C, 1498 Midgley FM, 112 Murayama S, 24 O’Connor GT, 1465 Lichtenberg R, 1124 Marciano F, 564 Mikuriya Y, 193, 893, 897 Musatti P, 219 O'Connor MK, 1295 Lichtenberg RC, 1281 Marco J, 1100 Milan Study on Atherosclero- Musco MH, 286 Oh B-H, 901 Lidell C, 521 Marcucci G, 722 sis and Diabetes (MiSAD) Myerburg RJ, 106 Oh D-J, 901 Marenzi GC, 1120 Lie KI, 53 Marinchak RA, 1114 Group, 134 Ohgushi M, 606 Lim Y-J, 1329 Milani M, 84 Ohman EM, 590 Marino B, 245, 1498 Naas AA, 328 Lima JAC, 1323 Mark DB, 590, 867 Milani RV, 397, 664 Nagase K, 897 Ohmura N, 862 Linares OA, 1381 Markianos M, 26, 366 Miller G, 1488 Nagaya N, 1502 Ohtahara A, 32 Lincoff AM, 286 Maron BJ, 840 Miller HI, 72 Nagayoshi H, 197 Okada R, 1137 Lindner JR, 16 Marrozzini C, 1314 Miller HS Jr., 360 Nahhas GT, 1370 Okano Y, 1502 Lindquist R, 1017 Martin K, 505 Miller LW, 451 Nakada |, 862 Oki T, 615, 921 Lin F-Y, 497 Martin RP, 781 Miller M, 1465 Nakamura H, 197, 676 Okubo M, 1137 Lin J-L, 497 Martone VD, 777 Miller NH, 58 Nakamura M, 966 Okuyama M, 28 Lin J-M, 497 Marwick TH, 914 Miller TA, 1258 Nakanishi N, 1502 Olsson G, 996 Linn W, 1255 Marzocchi A, 1314 Miller TD, 1295 Nakano T, 24 O'Meara J, 1465 Lip GYH, 1436 Masahiro |, 173 Miller TR, 1258 Nakasato M, 838 Ommen SR, 812 Liu MW, 472, 1334 Maseri A, 1, 1174 Mills RM Jr., 1412 Nakatani S, 5, 237 Omoto R, 1149 Livanis EG, 26, 366, 482 Mashiba H, 32 Minami K, 988 Nanas J, 529 O'Neill WW, 575, 1370 Llauger J, 15 Masuyama T, 1329 Minamino T, 475 Nanas JN, 570 Oneschuk L, 1255 Lloyd TR, 1141, 1143 Matas M, 681 Minassian A, 1375 Nanda NC, 436 Oren RM, 645 Loaiza A, 213 Mathew P, 12, 323 Minezaki KK, 1131 Naqvi TZ, 1521 Orfanakis AE, 160 Lock JE, 228 Mathiasen H, 1222 Mintz GS, 6, 703, 951 Narayan P, 1424 Ornato JP, 182 Lomsky M, 1447 Mathur A, 472, 1334 Mitchel YB, 38 Nardi M, 1261 O'Rourke DJ, 1465 London J, 1370 Matrazzo BA, 360 Mitchell A, 7 Narins B, 105 Qrskov H, 961 Lopes N, 1323 Matsuda H, 237 Mitchell LB, 1339 Nascimento R, 226 Ortolani P, 1314 Lopez de Sa E, 670 Matsumoto T, 1534 Mittleman MA, 1106, 1512 Nasir N Jr., 820, 1408 Osada N, 451 Lopez JAF, 373 Matsumura M, 1149 Miyao Y, 1534 Nasmith J, 391 Oshima A, 18 Lopez JJ, 1159 Matsuo H, 1556 Miyashita H, 18, 1471 Nasu M, 893, 897 Ostrzega E, 1061 Lopez-Sendén J, 670 Matsuoka H, 1556 Miyatake K, 5, 237 Nath S, 1185 Ozbeck S, 1012 Louis P, 33 Matsutani M, 1097 Miyazaki S, 1534 Navarro-Lopez F, 681 Love CJ, 1541 Matsuura Y, 475 Mizuno K, 197, 676 Neill CA, 112 Pacifico A, 436, 820, 1408 Lowe MD, 1239 Mauldin PD, 70 Mizuno 0, 1131 Nelson SD, 1541 Pagan-Carlo L, 689 Lucas C, 1255 Maxted W, 436 Mohr-Kahaly S, 1549 Nesto RW, 1106 Paganelli F, 815 Liichters G, 27 McCabe CH, 253 Moller J, 19 Neuberger S, 447 Page RL, 412 Liideritz 8, 28 McClellan JR, 600 Moller JH, 1147 Neuhaus K-L, 264 Pahor M, 120 Ludman P, 7 McCombs JL, 388 Mollod M, 1269 Neuzner J, 205 Palmerini T, 1314 Ludman PF, 30, 1239 McCullough PA, 575 Molnar J, 508, 1190 Newhouse TT, 1054 Palmer J, 15 Lumia F, 733 McCuskey CF, 1110 Momma K, 1285 Nguyen KN, 115 Panou F, 366 Lumley MA, 1170 McDonald RW, 173, 442 Monetti N, 957 Niccoli L, 188 Papademetriou V, 1424 Luo H, 1564, 1568 McKenna CA, 1252 Monin J-L, 713 Nichols TC, 1245 Papamichael C, 529 1726 THE AMERICAN JOURNAL OF CARDIOLOGY® VOL. 79 JUNE 15, 1997 Paparella N, 1421 Plotnick GD, 350 Riegger GAJ, 1273 Satomi G, 1285 Shotan A, 1061 Papatheou D, 494 Poehiman ET, 1267 Righini V, 84 Satomura K, 197 Shubrooks S, 1465 Paraskevaidis IA, 803 Poliac LC, 840 Rihal CS, 1005 Savageau J, 1095 Shubrooks SJ Jr., 873, Parisi AF, 1488 Pollock WE, 360 Ringqvist |, 521, 1507 Savage MP, 1104 1106 Park S-J, 901, 1524 Pomidossi G, 1100 Robbins JA, 431 Saxon LA, 1043 Shumaker SA, 1017 Park S-W, 901, 1524 Ponikowski P, 14 Robb JF, 1465 Sbarouni E, 87, 666 Shyr Y, 232 Parker KM, 58 Pons-Lladé G, 15 Roberts WC, 166, 457, 532, Schaal SF, 1541 Shyu K-G, 497 Parker MA, 178 Poole K, 1155 929, 1078, 1208, 1405 Schactman M, 253 Sidhu MK, 1397 Parks JM, 1334 Poole-Wilson PA, 1426 Rochitte CE, 1323 Schaefer S, 75 Siegel RJ, 1564, 1568 Parks MJ, 472 Popma JJ, 6, 128, 286, Rockstroh JK, 27 Schechtman KB, 1258 Sievanen H, 1414 Parrillo JE, 259 703, 951 Rodrigues AG, 829 Scheiber JF, 984 Sigurd B, 738 Parsons WJ, 270 Porcu E, 188 Rodriguez L-M, 309 Scheinman MM, 145, 1043, Simon 0, 1276 Partanen J, 487 Post MJ, 402 Roelandt JRTC, 7, 883, 1180 Simon WB, 1405 Pasceri V, 1, 1174 POST CABG Biobehavioral 1031 Schieffer HJ, 1194 Singh TP, 1283 Pascotto P, 500 Study Investigators, 1017 Rogolino A, 84 Schiele R, 264 Skala JA, 511 Pasquantonio J, 621 Posthuma DJ, 699 Rohtla KM, 1512 Schlepper M, 205 Skjeerbeek C, 961 Pasquini L, 1498 Powell CB, 1147 Rolf C, 521 Schlesinger Z, 611 Sloan EP, 2 Pasterkamp G, 402 Pratt CM, 43, 889 Roman AV, 373 Schmidt EB, 19 Slota PA, 1104 Paul DL, 209 PROLOG Investigators, 286 Roman MJ, 1482 Schmieder RE, 27 Smeets JLRM, 309 Pavlides GS, 1370 Propafenone Atrial Fibrillation Rombola AT, 160 Schmitt C, 621 Smith MJ, 1381 Pe E, 1054 Trial Investigators, 418 Romm F, 722 Schmitz 0, 961 Smith S, 1092 Pearson GD, 112 Provost K, 1276 Rénnemaa T, 25 Schob A, 706 Smith WH, 270 Pedersen F, 738 Prystowsky EN, 207 Ropers D, 856 Schoenfeld MR, 525, 991, Smolich JJ, 339, 516 Pedersen T, 64 Psarros L, 494 Rosamond W, 722 1432 Snader CE, 914 Pedersen-Bjergaard 0, 738 Puchrowicz-Ochocki S, 1370 Rosenqvist M, 1241 Schofield PM, 1239 Sniderman AD, 64 Peels CH, 334 Piitter K, 621 Rosenthal JE, 1190 Schémig A, 621 Snyder JT, 1106 Pelletier G, 829 Py A, 4 Rosito GA, 1252 Schroder K, 1516 Solodky A, 672 Pelosi F Jr., 532, 1405 Ross AM, 68, 1232 Schrott H, 1475 Solomon HS, 1252 Pelter MM, 639 Quinlivan EB, 1245 Ross RD, 691 Schuger CD, 963 Soman P, 8 Pepine CJ, 889 Quinton H, 1465 Rossi E, 1498 Schulz |, 1298 Somberg J, 508 Perego GB, 1120 Quiret J-C, 1375 Rossinen J, 487 Schussheim AE, 1070 Somberg JC, 1190 Pereira D, 226 Rossum AC, 1153 Schwaiger M, 539 Sonne HS, 9 Perez G, 106 Roth A, 611 Schwarzacher SP, 384 Sopko G, 889 Perez-Vizcayno MJ, 191 Rabinowe SL, 963 Roubin GS, 1334 Scibilia G, 1261 Soto F-X, 33 Perna S, 777 Rabinowitz A, 81 Roughneen PT, 1281 Sclarovsky S, 672 Spadaro LA, 128 Pernenkil R, 216 Radberg G, 1447 Rowland DG, 344, 1552 Scott CB, 763, 1065 Sparkman RS, 1306 Perrins EJ, 203 Radensky PW, 595 Rowiand LL, 1170 Secondary Prevention Rein- Spaulding C, 4 Perritt R, 1155 Radford MJ, 581 Roychoudhry D, 436 farction Israeli Nifedipine Specchia G, 188 PPPeeetttceehrr sseoMnnC ,JE YD,1, 213849551 3 RRRRaaaaiightnaamezkasaz nroi K HSMO,N,T U ,9, 18 422251 1 2 55 RRRRuuuubnddisddoiyy é RTT,M,D , ,6 1 70110925 4211 8 SSeeT7ggr1iao7alvl i aJ( ,S PJ6R,8I 1N9T1), S1tu3d9y4 Group, SSStpPaiRbeIlcNekTre rS SPtM,u, d 7y79 29G7 r,o u1p,5 496 74 PPeettehrisg KR,W ,8 9 10, 150, 502 RRaakmea naR,t h1a1n0 4 KB, 847 RRuysatni gTeJ JJ,r .2, 641 465 SSeelkli gTu,c h8i5 1 H, 1131 SSttaammbalteerl opBoSu,l o4s8 S, 529 Petitclerc R, 829 Rambaldi R, 1031 Rydman RJ, 2 Sempé S, 545 Stampfer MJ, 799 Petretta M, 564 Rampling MW, 1397 Senges J, 264 Starling MR, 1381 Peverill RE, 339, 516 Rande J-LD, 1343 Sengupta A, 1465 Stebbins AL, 1232 Pfeifer M, 1273 Randomized IABP Study Sabba C, 777 Senior R, 8 Steg PG, 1527 Pflugfelder PW, 630 Group, 590 Sadaniantz A, 1488 Senneca D, 58 Stein E, 1475 Phillips HR, 590 Rasmussen K, 19 Sahn DJ, 173, 442, 693 Serafini G, 1261 Stein EA, 38 Phillips PS, 191 Ratner DE, 559 Saidi A, 1561 SESAM Study Group, 727 Stein KM, 1482 Phillips RA, 505 Rautaharju P, 1289 Saito M, 862 Shaffer LM, 1436 Stein PK, 511 Picahrd AD, 703 Ravelli ACJ, 334 Saito Y, 1556 Shah AS, 216 Steinberg M, 94 Piccione W, 1124 Raviele A, 1421 Sakai K, 1392 Shah PK, 790, 1521 Steinman RT, 963 Pichard AD, 6, 951 Rawert M, 590 Sakata K, 1165 Shah S, 2 Stelken AM, 451 Pickard SD, 1170 Raymond RE, 1460 Sakata Y, 1329 Shahi CN, 980 Stephan PJ, 166 Pieper EG, 108, 334 Recto MR, 1561 Saksena S, 12, 323 Shanewise JS, 781 Stephens NG, 1239 Pieper KS, 539 Reicher-Reiss H, 674, 717 Sakuma H, 234 Shapira |, 355 Stern S, 23 Pieper M, 1012 Reiffel J, 816 Salive ME, 120 Shapiro LM, 30, 1239 Stiels B, 418 Piepoli M, 14 Reiffel JA, 315, 1048 Salomone 0, 1135 Sharma SK, 559 Stoler RC, 1159 Pileggi F, 1323 Reijs AEM, 1031 Samion H, 1430 Shaw LJ, 851 Stone FM, 1147 Pilotto A, 188 Reino AP, 373 Samore MH, 873 Sheffield D, 954 Stone MS, 689 Pines A, 355 Reisin L, 717 Samson RA, 696 Shepherd A, 1025 Stone PH, 253, 391, 1441 Pinski SL, 100, 1185, 686 Reisman M, 305 Samuels B, 1568 Sheps DS, 954 Stowers SA, 595 Piovaccari G, 1314 Reiter MJ, 315, 1048 Sandén W, 299 Shibuya T, 197 Strasberg B, 672 Pires LA, 963 Reller MD, 173, 442, 693 Sansoy V, 709 Shigemasa C, 32 Strasburger JF, 840 Pitkanen O-P, 25 Renfroe E, 1185 Santoli E, 84 Shim D, 1141, 1143 STRESS Trial Investigators, Pitschner HF, 205 Repetto S, 188 Santoro G, 1498 Shimada K, 1131 1104 Pitts WR, 1493 Ressencourt 0, 33 Sanyal R, 436 Shimakawa A, 234 Strickberger SA, 97, 815 Pizzulli L, 28 Rey J-L, 1375 Sapire DW, 388 Shimatani Y, 1392 Stroobandt R, 418 Planning and Steering Com- Rezler J, 768 Sathavorn C, 1409 Shindo M, 366 Strupp G, 727 mittees of the AFFIRM Rials SJ, 1114 Satler LF, 6, 538, 703, 951 Shinohara H, 921 Struthers AD, 328 Study for The NHLBI AF- Ricard P, 815 Sato H, 526, 1392 Shiota T, 173, 442, 693 Stuckey TD, 3 FIRM Investigators, 1198 Ricci R, 733 Sato S, 838 Shirakabe M, 28 Sueyoshi N, 1137 Plewan A, 621 Rice MJ, 173, 442 Sato T, 18, 1471 Shorofsky SR, 10, 150, 502, Sugiura T, 362, 1097 Plokker HWT, 1350 Rich MW, 216, 511 Satoh T, 1502 679 Sugiyama S, 606 AUTHOR INDEX 1727 Sukin CA, 275, 1159 Tischler MD, 513 van der Wall EE, 773 Watanabe T, 897 Wu S-N, 11 Sulkes J, 672 Tobert JA, 38 van Domburg RT, 7, 883, Waters D, 600 Wung S-F, 639 Sullivan JM, 847 Tobes MC, 105 1031 Watson DD, 270, 709 Wyse DG, 1185, 1339 Sullivan K, 447 Tobin MG, 686 Van Eenige MJ, 1355 Watson DG, 1147 Sundling N, 305 Tofler GH, 253, 391, 1252 van Gelder IC, 53 Waxman S, 1106 Yabuta K, 1137 Superko HR, 705 Toft E, 19 van Gilst WH, 53 Webb JG, 81 Yacoub M, 7 Supiano MA, 1381 Tohyama K, 1285 van Lankeren W, 699 Webb-Peploe K, 14 Yadav JS, 472, 1334 Supino P, 1482 Tollis G Jr., 1 Van Meter KW, 377 Weber H, 713 Yagi Y, 966 Sutherland S, 1289 Tomaselli GF, 970 van Ommen VG, 1012 Weber S, 4 Yaginuma T, 862 Sutton J, 209 Tomoike H, 28 Van Schuerbeeck E, 478 Wehbie RS, 1245 Yamada E, 1149 Sutton JM, 539 Topol EJ, 13, 286, 539, van Veldhuisen DJ, 978 Weidmann B, 959 Yamada H, 615, 921 Suzuki H, 838 748, 867, 1460 Vardas PE, 160 Weintraub RA, 3 Yamagishi M, 5, 237 Szabo BM, 978 Torosian T, 1170 Vasini P, 242 Weintraub WS, 406, 1453 Yamaguchi S, 28 Szelemej R, 14 Toth MJ, 1267 Vassilikos V, 494 Weisman HF, 286 Yamaguchi T, 801 Tousoulis D, 21 Vassilopoulos NG, 482 Weiss JS, 1190 Yamakado T, 24 Tabata H, 197 Toussaint M, 1230 Vega GL, 1298 Weiss RJ, 431 Yamamoto K, 1131 Tabata T, 615, 921 Toutouzas P, 21 Velvis H, 982 Weiss SR, 38 Yamamuro A, 223 Tai C-T, 11, 683, 905, 974 Toyoizumi H, 18, 1471 Vemmos C, 529 Weitzman S, 722 Yamaoka M, 28 Takagi T, 20, 223 Traboulsi M, 1339 Verhoef P, 799 Welin L, 996 Yamasaki F, 29 Takata J, 29 Tracy RP, 391 Verhorst PMJ, 1355 Wellens HJJ, 309, 1012 Yanagisawa A, 1165 Take S, 1097 Travin Ml, 600 Verlee P, 1465 Welling RC, 1355 Yano S, 193 Takehana K, 362 Treat-Jacobson D, 1017 Vermeer F, 727 Wen Z-C, 11, 683, 905, Yarows S, 1255 Takeshita S, 18, 1471 Treese N, 1360 Vick GW, 535 974 Yarzebski J, 1095 Talley JD, 70, 590 Trigano J, 815 Viik J, 1414 Wennberg D, 1465 Yasu T, 862 TAMI Investigators, 539 Trocino G, 883 Viikari JSA, 25 Wennerblom B, 1447 Yasue H, 606 Tamura A, 193, 893, 897 Trohman RG, 100, 686 Viitasalo M, 487 Wensing PJW, 402 Ye D, 1245 Tamura T, 801 Troszak E, 1370 Vincent RN, 447 Wertan MAC, 1114 Yi G, 1203 Tanaka H, 360 Truax WD, 377 Vinson. JM, 216 Wesslén L, 521 Yip ASB, 31 Tanzilli G, 1261 Tsagadopoulos D, 1424 Viskin S, 1180 Wessolossky MA, 873 Yock PG, 384 Tardif J-C, 829 Tsai C-H, 1546 Visser CA, 108, 334, 1355 West JA, 58 Yokote Y, 1149 Tarsi G, 957 Tsang TSM, 1232 Vitale NA, 1283 West of Scotland Coronary Yoshibayashi M, 1556 Tate DA, 1245 Tseng Y-Z, 497 Vitullo DA, 1281 Prevention Study Group, Yoshida A, 32 Tateishi H, 1392 Tsialtas D, 242 Vizza RF, 128 756 Yoshida K, 20, 223 Tauchert MO, 959 Tsiapras DP, 803 Vliegen HW, 773 Wettervik C, 1447 Yoshikawa H, 1538 TAUSA Investigators, 559 Tsutsui H, 5 Vo K, 742 Whiddon L, 166 Yoshikawa J, 20, 223 Taylor AW, 630 Tucker J, 2 Vogel RA, 350 White A, 722 Young H, 1518 Tcheng JE, 286 Tuzcu EM, 1460 Voigtlander T, 1360 Whitlow PL, 305, 748, 1460 Young M-L, 424 Tchou PJ, 686 Tygesen H, 1447 Volk H-D, 1426 Whittam JH, 34 Yu W-C, 683, 905, 974 Teirstein PS, 286 Voller H, 1516 Wieckhorst A, 1516 Yunis C, 1255 Teixeira F, 226 von Fisenne MJM, 727 Wilkins RG, 742 Uebis R, 727 Yunus A, 1339 Ten Cate FJ, 7 Vongpatanasin W, 492 Willett WC, 799 Ueda H, 1097 Tenaglia AN, 742 Voors AA, 1350 Williams AN, 281 Ueda K, 1149, 1392 Tenderich G, 988 Vuori |, 1414 Williams RR, 140 Zabalgoitia M, 1255 Ueda T, 475 Tenenbaum A, 355 Wilson Jl, 203 Zahn R, 264 Uematsu M, 237, 1502 Tentolouris C, 21 Waclawiw MA, 909 Wilson RA, 415 Zalenski RJ, 2 Ueng K-C, 683, 974 Terrin M, 1017 Wagner SR, 1549 Windeler J, 727 Zambahari R, 1430 Ueshima K, 966 Thadani U, 1025, 1401 Wahid F, 259 Winkel EM, 1124 Zanelli E, 219 Umeno T, 5 Themistoclakis S, 1421 Wahlers T, 89 Winters SL, 1054 Zanocco A, 500 Uretsky BF, 23 Theodorakis GN, 26, 366, Wakatsuki T, 921 Wirtzfeld A, 264 Zaret BL, 1 Usher B, 1289 482 Waldo AL, 43 Withagen AJ, 727 Zarich SW, 1106 Theroux P, 253 Wallace RB, 120 Witt SA, 380 Zarvalis E, 26 Thomas JD, 914 Vaccarino V, 581 Wallenstein S, 505 Wittenberg C, 216 Zatebradine Investigators, Thomas MR, 1012 Vaglio A, 1421 Walsh JT, 1364 Wolf J-E, 33 1401 Thompson B, 253, 1441 Vago T, 84 Walsh M, 980 Wolff GS, 424 Zebede J, 371 Thompson BW, 391 Vaitkus PT, 513, 1465 Walsh WF, 626 Wolford TL, 451 Zhao D, 23 Thomson SP, 812 Valdes A, 1570 Walter PF, 1409 Woo P, 1236 Zhu D, 696 Thornburg GA, 209 Valentine SM, 1110 Walters HL, 1283 Wood BC, 431 Zimarino M, 1230 Tieleman RG, 53 van Brussel BL, 1350 Walton MC, 209 Wood KA, 145, 1043 Zimetbaum P, 371 Tijssen JGP, 334 Vandenberg BF, 645 Wang C-H, 1546 Wood MA, 48, 1226 Zirbes M, 28 TIMI IIIB Investigators, 253 VandenBerg BJ, 259 Wang S, 1236 Wood ML, 1153 zu Knyphausen E, 988 TIMI Ill Registry Study Group, van den Berg MP, 53 Ward SR, 539 Woodard DA, 1412 Zupkis RV, 38 253, 1441 van den Bos AA, 1012 Warnes CA, 519 Working Group on Cardiac Al- Zwaag RV, 847 Timmermans C, 309 van der Lugt A, 699 Warth D, 305 lograft Vasculopathy, 89 Zwicke D, 2 Timmis GC, 1075 van der Veer N, 978 Wasserman K, 1120 Wrabec K, 14 Zyzanski S, 1017 1728 THE AMERICAN JOURNAL OF CARDIOLOGY® VOL. 79 JUNE 15, 1997 SUBJECT INDEX JANUARY 1, 1997 THROUGH JUNE 15, 1997 Acebutolol Alteplase Supersensitive Dilator Response to Nitroglycerin But Effectiveness of Digitalis With or Without Acebutolol in Comparison of Saruplase and Alteplase in Acute Myo- Not to Atrial Natriuretic Peptide in Spastic Coronary Preventing Atrial Arrhythmias After Coronary Artery cardial Infarction, 727 Arteries in Coronary Spastic Angina, 606 Surgery, 1114 Amiodarone Angiography Persistent Reduction of Mortality for Five Years After Efficacy, Safety, and Determinants of Conversion of Influence of Regional Cardiovascular Mortality on the One Year Of Acebutolo! Treatment Initiated During Atrial Fibrillation and Flutter With Oral Amiodarone, Use of Angiography After Acute Myocardial Infarc- Acute Myocardial Infarction, 587 53 tion, 575 Activity Mortality Benefit of Implantable Cardioverter-Defibrilla- Radial Versus Femoral Approach for Diagnostic Coro- Relation of Daily Activity Levels in Patients With tor Therapy in Patients With Persistent Malignant nary Angiography in Stable Angina Pectoris, 1239 Chronic Heart Failure to Long-Term Prognosis, 1364 Ventricular Arrhythmias Despite Amiodarone Treat- ment, 1180 Angioplasty Acute Coronary Syndromes Angiographic Evolution of Intracoronary Thrombus and Management of Unstable Angina Pectoris and Non—Q- Relation Between Amiodarone and Desethylamiodarone Dissection Following Percutaneous Transluminal Cor- Wave Acute Myocardial Infarction in the United Plasma Concentration and Ventricular Defibrillation onary Angioplasty (The Thrombolysis and Angioplasty States and Canada (The TIMI Ill Registry), 1441 Energy Requirements, 97 in Unstable Angina [TAUSA] Trial), 559 Adenosine Amyloidosis Angioplasty or Surgery for Multivessel Coronary Artery Effect of Theophylline on Adaptation of the Heart to Effectiveness of Cardiac Transplantation for Primary Disease: Comparison of Eligible Registry and Ran- Myocardial Ischemia During Percutaneous Translu- (AL) Cardiac Amyloidosis, 532 domized Patients in the EAST Trial and Influence of minal Coronary Angioplasty in Patients With Stable Anesthesia Administration Treatment Selection on Outcomes, 1453 Angina Pectoris, 475 Cost Effectiveness of Administration of Intravenous An- Angioscopy Variables Predictive of Early Angiographic Influence of Beta-Adrenergic and Vagal Activity on the esthetics for Direct-Current Cardioversion by Non- Outcome After Excimer Laser-Assisted Coronary An- Effect of Exogenous Adenosine on Supraventricular anesthesiologists, 686 gioplasty, 1343 Tachycardia Termination, 1628 Aneurysm Are the Results of Primary Percutaneous Transluminal Usefulness of Hemodynamic Changes During Adeno- Frequency and Outcome of Development of Coronary Coronary Angioplasty for Acute Myocardial Infarction sine Infusion in Predicting the Diagnostic Accuracy Artery Aneurysm After intracoronary Stent Placement Different During the ‘Off’ Hours?, 1527 of Adenosine Technetium-99m Sestamibi Single- and Angioplasty, 1104 Changes in Immediate Outcome of Percutaneous Photon Emission Computed Tomography (SPECT), Mitral and Tricuspid Valve Aneurysms Evaluated by Transluminal Coronary Angioplasty in Multivessel 1319 Transesophageal Echocardiography, 1269 Coronary Artery Disease in 1990 to 1991 Versus 1994 to 1995, 1389 Adhesion Molecules Angina Elevated Levels of Circulating Soluble Adhesion Mole- Additional Antianginal and Anti-Ischemic Efficacy of Comparison of Hospital Charges for Balloon Angio- cules in Patients With Nonrheumatic Aortic Stenosis, Mibefradil in Patients Pretreated With a Beta Blocker plasty and Surgical Repair in Children With Native 980 for Chronic Stable Angina Pectoris, 1025 Coarctation of the Aorta, 1142 Adrenomedullin Anginal Status and Prediction of Cardiac Events in Pa- Comparison of Intravascular Ultrasound Measurements Plasma Levels of Adrenomedullin in Primary and Sec- tients Enrolled in the Asymptomatic Cardiac Isch- at the Sites of Balloon Dilatations of Femoral Arteries ondary Pulmonary Hypertension in Patients <20 emia Pilot (ACIP) Study, 889 With Measurements of Postmortem Gross Arterial Years of Age, 1556 Cardiac Autonomic Function and Sensitivity to Pain in Segments at the Same Sites, 1564 Postmenopausal Women With Angina and Normal Comparison of Myocardial Contrast Echocardiography AFFIRM Coronary Arteries, 1174 for Assessing the Acute Protective Effects of Collat- Atrial Fibrillation Follow-Up Investigation of Rhythm Management—The AFFIRM Study Design, 1198 Comparison of Heparin Therapy for =48 Hours to eral Recruitment During Occlusion of the Left Ante- >48 Hours in Unstable Angina Pectoris, 259 rior Descending Coronary Artery at the Time of Elec- Albunex tive Angioplasty, 1329 Enhancement of Left Ventricular Cavity Opacification by Effect on Survival of Previous Angina Pectoris after Harmonic Imaging After Venous Injection of A/bunex, Acute Myocardial Infarction, 1534 Comparison of Patients With Either <70% Diameter Narrowing or =70% Narrowing of the Right Coro- 1657 Effects of Components of Meals (Carbohydrate, Fat, nary Artery When Performing Rotational Atherectomy Protein) in Causing Postprandial Exertional Angina Optimal A/bunex Dosing for Enhancement of Doppler on =1 Narrowing in the Left Coronary Arteries, 305 Pectoris, 1397 Tricuspid Regurgitation Spectra, 232 Comparison of Six-Month Results of Coronary Stenting Hemorrhagic Events During Therapy With Recombinant Alcohol Versus Balloon Angioplasty Alone in Patients With Tissue Plasminogen Activator, Heparin, and Aspirin Effects of Acute Alcohol Ingestion on Heart Rate Vari- Acute Myocardial Infarction, 1524 for Unstable Angina (Thrombolysis in Myocardial ability in Patients With Documented Coronary Artery Ischemia, Phase IIIB Trial), 391 Early Deterioration After Excimer Laser-Assisted Coro- Disease and Stable Angina Pectoris, 487 nary Angioplasty, 1230 Insulin-Like Growth Factor-1, Insulin, and Angina Pec- Alcoholic Cardiomyopathy toris Secondary to Coronary Atherosclerosis, Vaso- Effect of Cilostazol in Preventing Restenosis After Per- Long-Term Prognosis in Patients With Alcoholic Car- spasm, and Syndrome X, 961 cutaneous Transluminal Coronary Angioplasty, 1097 diomyopathy and Severe Heart Failure After Total Levels of Expression of P-Selectin, E-Selectin, and In- Effect of Continuous Quality Improvement Analysis on Abstinence, 1276 tracellular Adhesion Molecule-1 in Coronary Atherec- the Delivery of Primary Percutaneous Transluminal Allergy tomy Specimens from Patients With Stable and Un- Coronary Angiopiasty for Acute Myocardial Infarction, Incidence and Impact on Outcome of Streptokinase Al- stable Angina Pectoris, 742 1159 lergy in the GUSTO-I Trial, 1232 Management of Unstable Angina Pectoris and Non—Q- Effect of Coronary Angioplasty on Precordial QT Dis- Allograft Vascular Disease Wave Acute Myocardial Infarction in the United persion, 1339 Impact of Plaque Burden on Compensatory Enlarge- States and Canada (The TIMI Ili Registry), 1441 Frequency, Risk Factors, and Outcome for Bacteremia ment of Coronary Arteries in Cardiac Allograft Vas- Plasma Total Homocysteine and Risk of Angina Pecto- After Percutaneous Transluminal Coronary Angio- culopathy, 89 ris With Subsequent Coronary Artery Bypass Sur- plasty, 873 Alpert, Joseph Stephen gery, 799 Frequency and Outcome of Development of Coronary Joseph Stephen Alpert, MD: A Conversation With the Results of Coronary Stenting for Unstable Versus Sta- Artery Aneurysm After Intracoronary Stent Placement Editor, 1208 ble Angina Pectoris, 1314 and Angioplasty, 1104 ©1997 by Excerpta Medica, Inc. 1729 All rights reserved. Further ST Elevation at Reperfusion by Direct Percuta- Antiarrhythmic Therapy terial Peak Systolic Gradient in Adults Having Aortic neous Transluminal Coronary Angioplasty Predicts Mortality Trials With Implantable Defibrillators (Edito- Valve Replacement for Isolated Aortic Valve Stenosis, Poor Recovery of Left Ventricular Systolic Function in rial), 468 166 Anterior Wall AMI, 862 Antiarrhythmic Threrapy Apoptosis The Impact of Optimal Stenting Techniques on Cardiac Reproducibility of Drug Efficacy Predictions by Holter Apoptosis as a Possible Cause of Wall Thinning in Catheterization Laboratory Resource Utilization and Monitoring in the Electrophysiological Study Versus End-Stage Hypertrophic Cardiomyopathy, 1137 Costs, 275 Electrocardiographic Monitoring (ESVEM) Trial, 315 Arbutamine One-Week and Six-Month Angiographic Controls of Anticoagulation Comparison of Arbutamine and Exercise Echocardiog- Stent Implantation After Occlusive and Nonocclusive Coronary Stenting (Cordis) Without Anticoagulation, raphy in Diagnosing Myocardial Ischemia, 713 Dissection During Primary Balloon Angioplasty for 901 Acute Myocardial Infarction, 1592 Comparison of Tc-99m Sestamibi Perfusion Imaging Antidepressant Overdose and Echocardiography Using an Arbutamine \nfusion Outcome =10 Years After Successful Percutaneous Abnormal Ventricular Repolarization Mimicking Myocar- for the Detection of Coronary Artery Disease, 1518 Transluminal Coronary Angioplasty, 1005 dial Infarction After Heterocyclic Antidepressant Primary Angioplasty Versus Thrombolytic Therapy in Overdose, 242 Arginine Vasopressin the Treatment of Acute Myocardial Infarction, 264 Neurohormonal Tesponse to Head-Up Tilt and Its Role Anti-Heart Antibodies in Vasovagal Syncope, 1302 Publications Concerning Costs of Various Cardiovascu- Human Chagasic Disease Is Not Associated With an lar Procedures and Drugs, 70 Antiheart Humoral Response, 1135 Arrhythmia Results of Coronary Stenting for Unstable Versus Sta- Are Implantable Cardioverter-Defibrillators or Drugs ble Angina Pectoris, 1314 Antihypertensive Therapy _ More Effective in Prolonging Life?, 661 Effect of Atenolol on Birth Weight, 1436 Results of Directional Coronary Atherectomy in Fish Consumption, n-3 Fatty Acids in Cell Membranes, Northern New England, 1465 Antioxidants and Heart Rate Variability in Survivors of Myocardial Intake of Antioxidants Amiong American Cardiologists, Infarction With Left Ventricular Dysfunction, 1670 Timing and Mechanism of Death Determined Clinically 1558 After Primary Angioplasty for Acute Myocardial In- Incidence of Arrhythmias in Normal Pregnancy and Re- farction, 1586 Antithrombotic Therapy lation to Palpitations, Dizziness, and Syncope, 1061 Effect of Antithrombotic Therapy on Risk of Sudden Use of Evidence-Based Medical Therapy in Patients Mortality Benefit of Implantable Cardioverter-Defibrilla- Coronary Death in Patients With Congestive Heart Undergoing Percutaneous Coronary Revascularization tor Therapy in Patients With Persistent Malignant Failure, 909 in the United States, Europe, and Canada, 867 Ventricular Arrhythmias Despite Amiodarone Treat- Aortic Aneurysm ment, 1180 Angioscopy Cervical Aortic Arch With Aneurysm Formation, 112 Angioscopic Assessment of Coronary Lesions Underly- Myocardial Injury After Electrical Therapy for Cardiac ing Thrombus, 1106 Aortic Dissection Arrhythmias Assessed by Troponin-T Release, 1241 Angioscopic Characteristics of Coronary Narrowing in Usefulneass of Transesophageal Echocardiography in Predictors of Long-Term Survival in Patients With Ma- Patients With Recurrent Myocardial Ischemia After Detecting Changes in Flow Dynamics Responsible lignant Ventricular Arrhythmias, 1054 for Malperfusion Phenomena Observed During Sur- Myocardial Infarction, 1394 gery of Aortic Dissection, 1149 Reproducibility of Drug Efficacy Predictions by Holter Angioscopic Coronary Macromorohology After Throm- Monitoring in the Elecirophysiological Study Versus bolysis in Acute Myocardial Infarction, 197 Aortic Plaques Electrocardiographic Monitoring (ESVEM) Trial, 315 Frequency and Distribution of Atherosclerotic Plaques Angioscopy Variables Predictive of Early Angiographic in the Thoracic Aorta as Determined by Transesoph- Usefulness of Self-Administration of Intramuscular Li- Outcome After Excimer Laser-Assisted Coronary An- ageai Echocardiography in Patients With Coronary docaine in the Prehospital Setting for Ventricular gioplasty, 1343 Artery Disease, 27 Tachyarrhythmias Unassociated With Acute Myocar- Serum Lipid Profiles and the Presence of Yellow dial Infarction (The ‘‘Shahal’’ Experience in Israel), Plaque in Coronary Lesions In Vivo, 676 Aortic Regurgitation 611 Aortic Valve Prolapse and Aortic Regurgitation Associ- Angiotensin-Converting Enzyme Arterial Distensibility ated With Subpulmonic Ventricular Septal Defect, Inhibitors Intravascular Ultrasonic Evidence for Importance of 1285 Determinants of Appropriate Use of Angiotensin-Con- Plaque Distribution (Eccentric vs Circumferential) in verting Enzyme Inhibitors After Acute Myocardial In- Relation of Ultra-Low Frequency Heart Rate Variability Determining Distensibility of the Left Anterior De- farction in Persons =65 Years of Age, 581 to the Clinical Course of Chronic Aortic Regurgita- scending Artery, 1596 tion, 1482 Interaction Between Enalapril and Aspirin on Mortality Arteriography After Acute Myocardial Infarction: Subgroup Analysis Aortic Stenosis Prognostic Value of Dobutamine Stress Echocardiogra- of the Cooperative New Scandinavian Enalapril Sur- Comparison of Multiplane and Biplane Transesopha- phy in Patients Undergoing Diagnostic Coronary Ar- vival Study !l (CONSENSUS II), 115 geal Echocardiography in the Assessment of Aortic teriography, 1610 Reasons for Underuse of Angiotensin-Converting En- Stenosis, 436 Arteriosclerosis zyme Inhibitors in Patients With Heart Failure and Elevated Levels of Circulating Soluble Adhesion Mole- Absence of Human Herpesvirus Genome in Coronary Left Ventricular Dysfunction, 1118 cules in Patients With Nonrheumatic Aortic Stenosis, Atherosclerosis in Immunocompetent Patients, 1245 Relation of Functional Improvement in Congestive Heart 980 Failure After Quinapril Therapy to Peripheral Limita- Evaluation of the Significance of a Transvalvular Cathe- Artificial Intelligence tion, 635 ter on Aortic Valve Gradient in Aortic Stenosis: A Di- Cardiac Risk Stratification in Renal Transplantation Us- rect Hemodynamic and Doppler Echocardiographic ing a Form of Artificial Intelligence, 415 Anomalous Coronary Arteries Anomaious Origin of the Left Main Coronary Artery Study, 513 Aspirin from the Pulmonary Trunk Masquerading as Peripar- Transgastric Doppler Echocardiographic Assessment of Comparison of Heparin Therapy for =48 Hours to tum Cardiomyopathy, 1307 the Severity of Aortic Stenosis Using Multiplane >48 Hours in Unstable Angina Pectoris, 259 Value of Fast Gradient Echo Magnetic Resonance An- Transesophageal Echocardiography, 1273 Interaction Between Enalapril and Aspirin on Mortality giography as an Adjunct to Coronary Arteriography in Usefulness of Repeat Balloon Aortic Valvuloplasty in After Acute Myocardial Infarction: Subgroup Analysis Detecting and Confirming the Course of Clinically Children, 1141 of the Cooperative New Scandinavian Enaiapril Sur- Significant Coronary Artery Anomalies, 773 Aortic Valve vival Study ll (CONSENSUS ii), 115 Anterior Hemiblock Comparisons of Age, Gender, Number of Aortic Valve Pretreatment With Aspirin and Ticlodipine Confers Importance of Left Anterior Hemiblock Development in Cusps, Concomitant Coronary Artery Bypass Graft- Lower Thrombogenic Potential of Radiofrequency Inferior Wall Acute Myocardial Infarction, 672 ing, and Magnitude of Left Ventricular-Systemic Ar- Catheter Ablation, 494 1730) =THE AMERICAN JOURNAL OF CARDIOLOGY® VOL. 79 JUNE 15, 1997 Asymptomatic Cardiac Ischemia Efficacy of Atorvastatin in Primary Hypercholesterol- Atrial Septal Defect Anginal Status and Prediction of Cardiac Events in Pa- emia, 1248 Balloon Pulmonary Valvuloplasty for Pulmonary Valve tients Enrolled in the Asymptomatic Cardiac Isch- Atrial Compartment Surgery Stenosis With Atrial Septal Defect, 838 emia Pilot (ACIP) Study, 889 Influence of Additional Partition on the Recovery of Pericardial Effusion in Adults Undergoing Surgical Re Atenolol Atrial Function After Atrial Compartment Operation pair of Atrial Septal Defect, 1706 Effect of Atenolol on Birth Weight, 1436 for Atrial Fibrillation, 497 Atrial Thrombi Effects of Atenolol Versus Enalapril on Cardiovascular Atrial Fibrillation/Flutter Vaiue of Cardiac Ultrafast Computed Tomography for Fitness and Serum Lipids in Physically Active Hyper- Atrial Fibrillation Follow-Up Investigation of Rhythm Detecting Right Atrial Thrombi in Chronic Atrial Fib- tensive Men, 1065 Management—The AFFIRM Study Design, 1198 rillation, 1292 Atherectomy Atrial Fibrillation Induced by Atrioventricular Nodal Re- Atrioventricular Block Comparison of Balloon Angioplasty Versus Debulking entrant Tachycardia, 681 Frequency and Prognostic Significance of High-Degree Devices Versus Stenting in Right Coronary Ostial Le- Clinical Usefulness of Slow Pathway Ablation in Pa- Atrioventricular Block in Patients With a First Non— sions, 1334 tients With Both Paroxysmal Atrioventricular Nodal Q-Wave Acute Myocardial Infarction, 674 Comparison of Patients With Either <70% Diameter Reentrant Tachycardia and Atrial Fibrillation, 1421 Atrioventricular Nodal Reentrant Narrowing or =70% Narrowing of the Right Coro- Comparison of Oral Propafenone and Sotalol as an Ini- Tachycardia nary Artery When Performing Rotational Atherectomy tial Treatment in Patients With Symptomatic Parox- Atrial Fibrillation Induced by Atrioventricular Nodal Re- on =1 Narrowing in the Left Coronary Arteries, 305 ysmal Atrial Fibrillation, 905 entrant Tachycardia, 681 Impact of Restenosis After Optimal Directional Coro- Cost Effectiveness of Administration of Intravenous An- Electrophysiologic Characteristics and Radiofrequency nary Atherectomy on Regional Left Ventricular Func- esthetics for Direct-Current Cardioversion by Non- Catheter Ablation of Fast-Slow Form Atrioventricular tion, 545 anesthesiologists, 686 Nodai Reentrant Tachycardia, 683 Long-Term Clinical Follow-up After Directional Coro- Effect of Electrode Position on Outcome of Low-Energy Atrioventricular Node nary Atherectomy, 553 Intracardiac Cardioversion of Atrial Fibrillatici:, 621 Similar Time-Dependent Recovery Property of Fast and Results of Directional Coronary Atherectomy in Effectiveness of Digitalis With or Without Acebutolol In Slow Atrioventricular Nodal Pathways, 424 Northern New England, 1465 Preventing Atrial Arrhythmias After Coronary Artery Atrium Surgery, 1114 Transluminal Extraction Atherectomy for Restenosis Stability of Left Atrial Spontaneous Echo Contrast at Following Palmaz-Schatz Stent Implantation, 801 Effectiveness of Sotalol for Atrial Flutter in Children Af- Repeat Transesophageal Echocardiography in Pa- ter Surgery for Congenital Heart Disease, 92 tients With Mitral Stenosis, 516 Usefulness of Directional Coronary Atherectomy in Pa- Efficacy, Safety, and Determinants of Conversion of tients With Acute Anterior Myocardial Infarction, ine 1392 Atrial Fibrillation and Flutter with Oral Amiodarone, Early Chronotropic Incompetence Predicts the Need for 53 Atropine During Dobutamine Stress Echocardiogra- Atherosclerosis Efficacy of Intravenous Propafenone in Termination of phy, 365 Comparison of Men Versus Women in Cross-Sectional Atrial Flutter by Overdrive Transesophageal Pacing Prognostic Significance of Systolic Blood Pressure Area Luminal Narrowing, Quantity of Plaque, and Lu- Previously Ineffective, 500 Changes During Dobutamine-Atropine Stress Tech- men Location in Coronary Arteries by Intravascular Evaluation of Left Atrial Appendage Function by Mea- netium-99m Sestamibi Perfusion Scintigraphy in Pa- Ultrasound in Patients With Stable Angina Pectoris, surement of Changes in Flow Velocity Patterns After tients With Chest Pain and Known or Suspected 1601 Electrical Cardioversion in Patients With Isolated Coronary Artery Disease, 1031 Effect of Pravastatin (10 mg/day) on Progression of Atrial Fibrillation, 615 Coronary Atherosclerosis in Patients With Serum To- Influence of Additional Partition on the Recovery of ACaurdtioacn oAmutiocno miNce rFuvnoctuison aSnyd sSteensmit ivity to Pain in tAanlg iCohgorlaepshtiercoall lyL evDeolcsu mfernomt ed1 60C otroo n2a2r0y mArgt/edrly aDnids- fAtorri aAlt riFauln cFtiiborinl laAtfitoenr, A4t9ri7a l Compartment Operation PCoorsotnmaernyo pAarutseraile s,W o1m1e7n4 With Angina an? Normal ease, 893 Intravenous Clofilium for Conversion of Atrial Fibrilla- Effect of Endoscopic Transthoracic Sympathicotomy on Elevated High-Density Lipoprotein Cholesterol, Not Pro- tion, 94 Heart Rate Variability in Severe Angina Pectoris, tective in the Presence of Homocysteinemia, 705 P-Wave Morphology During Right Atrial Pacing Before 1447 Frequency and Distribution of Atherosclerotic Plaques and After Atrial Flutter Ablation—A New Marker for Gender-Specific Differences in the QT Interval and the in the Thoracic Aorta as Determined by Transesoph- Success, 1417 Effect of Autonomic Tone and Menstrual Cycle in ageal Echocardiography in Patients With Coronary Propafenone for Conversion of Atrial Fibrillation, 418 Healthy Adults, 178 Artery Disease, 23 Prospective Assessment of the Minimum Energy Autonomic Tone Impact of Local Atherosclerotic Remodeling on the Cal- Needed for External Electrical Cardioversion of Atrial Influence of Beta-Adrenergic and Vagal Activity on the culation of Percent Luminal Narrowing, 402 Fibrillation, 815 Effect of Exogenous Adenosine on Supraventricular Insulin-Like Growth Factor-1, insulin, and Angina Pec- Risk of Thromboembolism in Chronic Atrial Flutter, Tachycardia Termination, 1628 toris Secondary to Coronary Atherosclerosis, Vaso- 1043 spasm, and Syndrome X, 961 AV Synchrony Transesophageal Echocardiographic Predictors for The Pacemaker Syndrome—A Matter of Definition, Remodeling of Atherosclerotic Coronary Arteries As- Maintenance of Sinus Rhythm After Electrical Car- 1226 sessed With intravascular Ultrasound In Vitro, 699 dioversion of Atrial Fibrillation, 1355 Athletes Atrial Myxoma An Echocardiographic Study Comparing Male Swedish Genetic Heterogeneity of Familial Atrial Myxoma Syn- Bacteremia Elite Orienteers With Other Elite Endurance Athietes, dromes (Carney Complex), 994 Frequency, Risk Factors, and Outcome for Bacteremia 521 Atrial Natriuretic Peptide After Percutaneous Transluminal Coronary Angio- Comparison of Left Ventricular Function Using lsomet- Effect of the Maze Procedure for Atrial Fibrillation on plasty, 873 ric Exercise Doppler Echocardiography in Competitive Atrial and Brain Natriuretic Peptide, 966 Baffle Fenestration Runners and Weightlifters Versus Sedentary Individu- Left Atrial Function and Atrial Natriuretic Factor/Cyclic Transcatheter Fenestration Dilation and/or Creation in als, 355 Guanosine Monophosphate Changes in DOD and VWI Postoperative Fontan Patients, 228 Atorvastatin Pacing Modes, 366 Beta Blockers Comparison of One-Year Efficacy and Safety of Ator- Supersensitive Dilator Response to Nitrog/ycerin But Additional Antianginal and Anti-ischemic Efficacy of vastatin Versus Lovastatin in Primary Hypercholester- Not to Atrial Natriuretic Peptide in Spastic Coronary Mibefradil in Patients Pretreated With a Beta Blocker olemia, 1475 Arteries in Coronary Spastic Angina, 606 for Chronic Stable Angina Pectoris, 1025 SUBJECT INDEX 1731 Correlation Between Time-Domain Measures of Heart Cardiac Events Transesophageal Echocardiographic Predictors for Rate Variability and Scatterplots in Patients With Anginai Status and Prediction of Cardiac Events in Pa- Maintenance of Sinus Rhythm After Electrical Car- Healed Myocardial Infarcts and the Influence of Me- tients Enrolled in the Asymptomatic Cardiac Isch- dioversion of Atrial Fibrillation, 1355 toprolol, 412 emia Pilot (ACIP) Study, 889 Cardioverter-Defibrillator Practical Guidelines for Initiation of Beta-Adrenergic Cardiac Masses Are Implantable Cardioverter-Defibrillators or Drugs Blockade in Patients With Chronic Heart Failure, 794 Right-Sided Cardiac Tumors Detected by Transesopha- More Effective in Prolonging Life?, 661 Sotalo/ for Ventricular Tachyarrhythmias: Beta-Blocking geal Echocardiography and Its Usefulness in Differ- Clinical Predictors of Defibrillation Energy Require- and Class Ill Contributions, and Relative Efficacy Ver- entiating the Benign from the Malignant Ones, 781 ments, 205 sus Class | Drugs After Prior Drug Failure, 1048 Cardiac Rehabilitation Clinical Predictors of Transvenous Defibrillation Energy Blood Flow Benefits of Cardiac Rehabilitation and Exercise Training Requirements, 150 Measurement of Coronary Blood Flow Velocity During in Elderly Women, 664 Effect of Preexisting Epicardial Patch Electrodes on De- Handgrip Exercise Using Breath-Hold Velocity En- Contemporary Cardiac Rehabilitation Services, 1075 fibrillation Thresholds of Unipolar Defibrillators, 1408 coded Cine Magnetic Resonance Imaging, 234 Effects of Cardiac Rehabilitation, Exercise Training, and Incidence and Implications of Abrasion of Implantable Blood Pressure Weight Reduction on Exercise Capacity, Coronary Cardioverter-Defibrillator Leads, 1409 Association of Systolic Blood Pressure at Time of Myo- Risk Factors, Behavioral Characteristics, and Quality Mortality Benefit of Implantable Cardioverter-Defibrilla- cardial Ischemia With Angina Pectoris During Exer- of Life in Obese Coronary Patients, 397 tor Therapy in Patients With Persistent Malignant cise Testing, 954 Cardiogenic Shock Ventricular Arrhythmias Despite Amiodarone Treat- Delayed Recovery of Postexercise Blood Pressure in Usefulness of Coronary Stenting for Cardiogenic Shock, ment, 1180 Patients With Chronic Heart Failure, 1701 81 Mortality Trials With Implantable Defibrillators (Edito- Prognostic Significance of Systolic Blood Pressure Cardiomyopathy rial), 468 Changes During Dobutamine-Atropine Stress Tech- The Acute Hemodynamic Effects of Right Ventricular Right and Left Ventricular Hemodynamic Performance netium-99m Sestamibi Perfusion Scintigraphy in Pa- Septal Pacing in Patients With Congestive Heart Fail- During Sustained Ventricular Tachycardia, 323 tients With Chest Pain and Known or Suspected ure Secondary to Ischemic or Idiopathic Dilated Car- Spontaneous Ventricular Tachycardia Treated by Anti- Coronary Artery Disease, 1031 diomyopathy, 679 tachycardia Pacing, 820 Brachial Artery Dilation : Anomalous Origin of the Left Main Coronary Artery Carotid Artery Dissection Effect of Acute Cigarette Smoking on Endothelium-De- from the Pulmonary Trunk Masquerading as Peripar- Association Between Plasma Homocysteine and Extra- pendent Brachial Artery Dilation in Healthy Individu- tum Cardiomyopathy, 1307 cranial Carotid Arterial Disease in Older Persons, als, 529 Apoptosis as a Possible Cause of Wall Thinning in 1432 Brain Natriuretic Peptide End-Stage Hypertrophic Cardiomyopathy, 1137 Association of Extracranial Carotid Arterial Disease, Effect of the Maze Procedure for Atrial Fibrillation on Comparison of Morphologic Assessment of Hypertro- Prior Atherothrombotic Brain Infarction, Systemic Hy- Atrial and Brain Natriuretic Peptide, 966 phic Cardiomyopathy by Magnetic Resonance Versus pertension, and Left Ventricular Hypertrophy With the Brain SPECT Echocardiographic Imaging, 1651 Incidence of New Antithrombotic Brain Infarction at Technetium-99m-HMPAO Brain SPECT in Patients Dispersion of Ventricular Activation and Refractoriness 45-Month Folllow-Up in 1,482 Older Patients, 991 With Syndrome X, 959 in Patients With Idiopathic Dilated Cardiomyopathy, Serum Ferritin Is Not a Risk Factor for Extracranial Ca- Bundle Branch Block 970 rotid Arterial Disease in Men and Women Aged New Criteria for the Diagnosis of Healed Inferior Wall Results of Coronary Artery Bypass Grafting by a Single =60 Years, 525 Myocardial Infarction in Patients With Left Bundle Surgeon in Patients with Left ventricular Ejection CATCH 22 Branch Block, 19 Fractions [sc256]30%, 1573 Deletions in Chromosome 22q11 Region in Cervical The Signal-Averaged Electrocardiogram Is of Limited The Signal-Averaged Electrocardioaram Is of Limited Aortic Arch, 388 Value in Patients With Bundle Branch Block, and Di- Value in Patients With Bundle Branch Block, and Di- lated Cardiomyopathy in Predicting Inducible Ventric- lated Cardiomyopathy in Predicting Inducible Ventric- Catecholamines Clinical Symptoms of Mitra! Valve Proplapse Are Re- ular Tachycardia or Death, 154 ular Tachycardia or Death, 154 lated to Hypomagnesemia and Attenuated by Mag- Burns Usefulness of Signal-Averaged Electrocardiography in nesium Supplementation, 768 Nature and Determinants of Skin “Burns” After Trans- Evaluation of Idiopathic-Dilated Cardiomyopathy in thoracic Cardioversion, 689 Families, 1203 Catheter Effect of Electrode Position on Outcome cf Low-Energy Cardiovascular Disease Intracardiac Cardioversion of Atrial Fibrillation, 621 Prevalence of Echocardiographic Findings in 554 Men Caffeine and in 1,243 Women Aged >60 Years in a Long- Influence of Guiding Catheter Selection on the Mea- Hemodynamic Effects of Acute Caffeine Ingestion in Term Health Care Facility, 379 surement of Coronary Flow Reserve, 703 Young Adults, 696 Catheterization Cardioversion Calcium Effect of Electrode Position on Outcome of Low-Energy Effects of Thrombolytic Regimen, Early Catheterization, Determinants of Transplant-Related Coronary Calcium Intracardiac Cardioversion of Atrial Fibrillation, 621 and Predischarge Angiographic Variables on Six- Detected by Ultrafast Computed Tomography Scan- Week Left Ventricular Function, 539 Efficacy, Safety, and Determinants of Conversion of ning, 1606 Single Therapeutic Catheterization to Treat Coexisting Atrial Fibrillation and Flutter with Oral Amiodarone, Possible Association of Thrombotic, Nonbacterial Vege- 53 Coarctation of the Aorta and Patent Ductus Arterio- tations of the Mitral Ring—Mitral Annular Calcium Evaluation of Left Atrial Appendage Function by Mea- sus, 535 and Stroke, 1712 surement of Changes in Flow Velocity Patterns After Telephone Reporting of Cardiac Procedure Results to Relation of Coronary Calcium Score by Electron Beam Electrical Cardioversion in Patients With Isolated Primary Care Physicians, 984 Computed Tomography to Arteriographic Findings in Atrial Fibrillation, 615 Werner Forssmann: A Pioneer of Cardiology, 651 Asymptomatic and Symptomatic Adults, 128 Intravenous Clofilium for Conversion of Atria! Fibrilla- Cell Adhesion Molecules Calcium Antagonists tion, 94 Levels of Expression of P-Selectin, E-Selectin, and In- “Cardioprotection’’—Not All Caicium Antagonists Are Nature and Determinants of Skin ‘‘Burns’’ After Trans- tracellular Adhesion Molecule-1 in Coronary Atherec- Created Equal: Second Round, 788 thoracic Cardioversion, 689 tomy Specimens from Patients With Stable and Un- Comparison of Verapamil Versus Felodipine on Heart Prospective Assessment of the Minimum Energy stable Angina Pectoris, 742 Rate Variability After Acute Myocardial Infarction, Needed for External Electrical Cardioversion of Atrial Cervical Aortic Arch 564 Fibrillation, 815 Cervical Aortic Arch With Aneurysm Formation, 112 1732 THE AMERICAN JOURNAL OF CARDIOLOGY® VOL. 79 JUNE 15, 1997